Format

Send to

Choose Destination
J Laryngol Otol. 2002 Oct;116(10):849-50.

A novel treatment for patients with hereditary haemorrhagic telangiectasia.

Author information

1
Department of Otolaryngology, Antrim Area Hospital, Antrim, Northern Ireland, UK. turlough.farnan@ntlworld.com

Abstract

Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by dermal, mucosal, and visceral telangiectases as well as pulmonary and cerebral arteriovenous malformations. Recurrent epistaxis occurs in the majority of patients, and by the very nature of the thin walled vessels involved it is often refractory to conventional forms of treatment. We present the case of an 82-year-old lady with intractable epistaxis secondary to HHT, that was successfully controlled by the application of fibrin glue.

PMID:
12437844
DOI:
10.1258/00222150260293709
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center